These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 22863010)

  • 21. Small Molecule Supplements Improve Cultured Megakaryocyte Polyploidization by Modulating Multiple Cell Cycle Regulators.
    Zou X; Qu M; Fang F; Fan Z; Chen L; Yue W; Xie X; Pei X
    Biomed Res Int; 2017; 2017():2320519. PubMed ID: 29201898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aurora B is dispensable for megakaryocyte polyploidization, but contributes to the endomitotic process.
    Lordier L; Chang Y; Jalil A; Aurade F; Garçon L; Lécluse Y; Larbret F; Kawashima T; Kitamura T; Larghero J; Debili N; Vainchenker W
    Blood; 2010 Sep; 116(13):2345-55. PubMed ID: 20548097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphorylation of ribosomal protein S6 kinase 1 at Thr421/Ser424 and dephosphorylation at Thr389 regulates SP600125-induced polyploidization of megakaryocytic cell lines.
    Li CL; Yang JG; Lin D; Zhao YS; Liu S; Xing SN; Zhao S; Chen CQ; Jiang ZM; Pu FF; Cao JP; Ma DC
    PLoS One; 2014; 9(12):e114389. PubMed ID: 25486532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miRNAs can increase the efficiency of ex vivo platelet generation.
    Emmrich S; Henke K; Hegermann J; Ochs M; Reinhardt D; Klusmann JH
    Ann Hematol; 2012 Nov; 91(11):1673-84. PubMed ID: 22763947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic target.
    Patel AV; Eaves D; Jessen WJ; Rizvi TA; Ecsedy JA; Qian MG; Aronow BJ; Perentesis JP; Serra E; Cripe TP; Miller SJ; Ratner N
    Clin Cancer Res; 2012 Sep; 18(18):5020-30. PubMed ID: 22811580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of Alisertib (MLN8237), an investigational small-molecule inhibitor of aurora A kinase using novel in vivo pharmacodynamic assays.
    Manfredi MG; Ecsedy JA; Chakravarty A; Silverman L; Zhang M; Hoar KM; Stroud SG; Chen W; Shinde V; Huck JJ; Wysong DR; Janowick DA; Hyer ML; Leroy PJ; Gershman RE; Silva MD; Germanos MS; Bolen JB; Claiborne CF; Sells TB
    Clin Cancer Res; 2011 Dec; 17(24):7614-24. PubMed ID: 22016509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma.
    Görgün G; Calabrese E; Hideshima T; Ecsedy J; Perrone G; Mani M; Ikeda H; Bianchi G; Hu Y; Cirstea D; Santo L; Tai YT; Nahar S; Zheng M; Bandi M; Carrasco RD; Raje N; Munshi N; Richardson P; Anderson KC
    Blood; 2010 Jun; 115(25):5202-13. PubMed ID: 20382844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model.
    Mercher T; Wernig G; Moore SA; Levine RL; Gu TL; Fröhling S; Cullen D; Polakiewicz RD; Bernard OA; Boggon TJ; Lee BH; Gilliland DG
    Blood; 2006 Oct; 108(8):2770-9. PubMed ID: 16804112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-resistant aurora A mutants for cellular target validation of the small molecule kinase inhibitors MLN8054 and MLN8237.
    Sloane DA; Trikic MZ; Chu ML; Lamers MB; Mason CS; Mueller I; Savory WJ; Williams DH; Eyers PA
    ACS Chem Biol; 2010 Jun; 5(6):563-76. PubMed ID: 20426425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of Aurora A enhances radiosensitivity in selected lung cancer cell lines.
    Liu N; Wang YA; Sun Y; Ecsedy J; Sun J; Li X; Wang P
    Respir Res; 2019 Oct; 20(1):230. PubMed ID: 31647033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of mitotic Aurora kinase A by alisertib induces apoptosis and autophagy of human gastric cancer AGS and NCI-N78 cells.
    Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Wang NJ; Zhao RJ; Zhou SF
    Drug Des Devel Ther; 2015; 9():487-508. PubMed ID: 25609923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancer.
    Carol H; Boehm I; Reynolds CP; Kang MH; Maris JM; Morton CL; Gorlick R; Kolb EA; Keir ST; Wu J; Wozniak AE; Yang Y; Manfredi M; Ecsedy J; Wang J; Neale G; Houghton PJ; Smith MA; Lock RB
    Cancer Chemother Pharmacol; 2011 Nov; 68(5):1291-304. PubMed ID: 21448591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. c-Myc Is a Major Determinant for Antitumor Activity of Aurora A Kinase Inhibitor MLN8237 in Thyroid Cancer.
    Li Y; Li X; Pu J; Yang Q; Guan H; Ji M; Shi B; Chen M; Hou P
    Thyroid; 2018 Dec; 28(12):1642-1654. PubMed ID: 30226440
    [No Abstract]   [Full Text] [Related]  

  • 34. Overexpression of cyclin D1 in the Dami megakaryocytic cell line causes growth arrest.
    Wilhide CC; Van Dang C; Dipersio J; Kenedy AA; Bray PF
    Blood; 1995 Jul; 86(1):294-304. PubMed ID: 7795236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. K-252a-induced polyploidization and differentiation of a human megakaryocytic cell line, Meg-J: transient elevation and subsequent suppression of cyclin B1 and cdc2 expression in the process of polyploidization.
    Iwabe K; Teramura M; Yoshinaga K; Kobayashi S; Hoshikawa Y; Maeda T; Hatakeyama M; Mizoguchi H
    Br J Haematol; 1998 Aug; 102(3):812-9. PubMed ID: 9722312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Megakaryocyte polyploidization is associated with decreased expression of polo-like kinase (PLK).
    Yagi M; Roth GJ
    J Thromb Haemost; 2006 Sep; 4(9):2028-34. PubMed ID: 16805859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Megakaryocytes express functional Aurora-B kinase in endomitosis.
    Geddis AE; Kaushansky K
    Blood; 2004 Aug; 104(4):1017-24. PubMed ID: 15130946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alisertib (MLN8237) an investigational agent suppresses Aurora A and B activity, inhibits proliferation, promotes endo-reduplication and induces apoptosis in T-NHL cell lines supporting its importance in PTCL treatment.
    Qi W; Spier C; Liu X; Agarwal A; Cooke LS; Persky DO; Chen D; Miller TP; Mahadevan D
    Leuk Res; 2013 Apr; 37(4):434-9. PubMed ID: 23153524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction between protein kinase C and actin in megakaryocyte polyploidization.
    Baatout S; Chatelain B; Staquet P; Symann M; Chatelain C
    Anticancer Res; 1999; 19(5B):4193-8. PubMed ID: 10628374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A unique role of GATA1s in Down syndrome acute megakaryocytic leukemia biology and therapy.
    Xavier AC; Edwards H; Dombkowski AA; Balci TB; Berman JN; Dellaire G; Xie C; Buck SA; Matherly LH; Ge Y; Taub JW
    PLoS One; 2011; 6(11):e27486. PubMed ID: 22110660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.